| Description | 5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole can be used in the synthesis of heterocyclic compounds to inhibit HIF pathway activity. |
| molecular weight | 311.22 |
| Molecular formula | C12H8F3N5O2 |
| CAS | 1570493-58-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 50 mg/mL (160.66 mM) |
| References | 1. Philip Jones, et al. Salts of heterocyclic modulators of hif activity for treatment of disease. EP3110420B1 |
5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
CAS No.: 1570493-58-1
5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole can be used in the synthesis of heter
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.